HOME >> MEDICINE >> NEWS
Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia

CHICAGO - An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.

"Patients taking dasatinib achieve complete cytogenetic response - absence of the mutated protein that drives this disease - more rapidly than we've observed historically using the current front-line therapy. Side effects are very manageable," says Ehab L. Atallah, M.D., lead author of the study and a fellow in M. D. Anderson's Department of Leukemia. Atallah presented study results at the annual meeting of the American Society of Clinical Oncology in Chicago Saturday June 2nd, 2007. The clinical trial remains in progress with 35 patients enrolled.

Dasatinib, known commercially as Sprycel and produced by Bristol-Myers Squibb, was approved by the U.S. Food and Drug Administration a year ago for use by patients whose disease is unresponsive to or becomes resistant to the front-line therapy imatinib. Both drugs bind to and block a genetically flawed protein known as BCR-ABL, which causes the disease. Atallah explains that dasatinib binds to both forms BCR-ABL while imatinib blocks only one.

"Our hypothesis is that treating with dasatinib first will produce an earlier response, which may translate to a better overall survival," Atallah says. "We haven't proved that here, but these early results are encouraging."

Atallah and colleagues evaluated 35 patients who enrolled in the clinical trial between November 2005 and December 2006. Patients receive either 100 mg of dasatinib once daily or 50 mg twice daily.

Thirty four patients had been on the clinical trial for at least three months when Atallah and lead researcher Jorge Cortes, M.D., professor in the Department of Leukemia, evaluated their data. They found that 77 percent of pati
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
2-Jun-2007


Page: 1 2

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Most seniors now have drug coverage, U-M study shows
3. Wireless technology shows promise in diagnosing pediatric intestinal disease
4. Study shows radiofrequency ablation highly effective in treating kidney tumors
5. Method shows promise for early detection of pancreatic cancer
6. Organic farming can feed the world, U-M study shows
7. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
8. Borderline personality disorder shows improvements with intensive psychotherapy
9. New drug shows promise in treatment of advanced thyroid cancer
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... , ... December 13, 2018 , ... LifeStation today announced the availability of Find My ... Find My Loved One gives caregivers the ability to locate a loved one at any ... provides unmatched additional peace of mind for children, relatives, and caregivers. , Here’s ...
(Date:12/10/2018)... LOMA LINDA, Calif. (PRWEB) , ... December 10, 2018 , ... ... study assessing all 18 major freight railyards in California and found a link with ... published in Preventive Medicine Reports. , This large-scale railyard study is ...
(Date:12/8/2018)... ... December 07, 2018 , ... Garland was recently honored ... of supporting non-profit organizations through fun, creative and thoughtful fundraising. Garland’s philanthropic initiative ... $400,000 for charities in northeast Ohio and across the country over the last ...
(Date:12/6/2018)... Mass. (PRWEB) , ... December 06, 2018 , ... ... plant cured the tropical disease schistosomiasis significantly faster than the drug most commonly ... conducted in the Democratic Republic of Congo. The study’s authors, including a professor ...
(Date:12/5/2018)... and DALLAS, Texas (PRWEB) , ... December 05, ... ... again proved its leading SkinPen Precision device is setting a new standard as ... record-setting Aesthetics Everything win. , Each year this award is presented at the ...
Breaking Medicine News(10 mins):
(Date:12/13/2018)... ... December 13, 2018 , ... Sponsorship and ... 1 to 4, 2019, at the Hyatt Regency in Chicago. , The ... as 4,200-plus attendees. In attendance will be the top C-suite executives from hospitals ...
(Date:12/10/2018)... ... December 10, 2018 , ... Mothers Against Drunk Driving ... MADD in 2000 after her 16-year-old daughter, Helen Marie, was killed by a drunk ... in Miami on a clear June afternoon. , “I landed in MADD’s capable lap, ...
(Date:12/8/2018)... (PRWEB) , ... December 07, 2018 , ... Nationally, it ... more that have dental insurance benefits that are seriously lacking and make it challenging ... Veranda Dentistry believes that dental care should be accessible and affordable to everyone, with ...
Breaking Medicine Technology:
Cached News: